Other contributors include strong expression of NKG2D, a type II transmembrane receptor involved in the killing response (64), on infiltrating CD8+ T cells and NK cells; overexpression of activating NKG2D ligands (UL16-binding protein, MICA) on HFs; and downregulation of immunosuppressants (31). The gene discussed is CD8A; the disease is Hand-foot syndrome.